Graphene oxide-silver nanocomposite as a promising biocidal agent against methicillin-resistant Staphylococcus aureus

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 6847-6861

  de Moraes, Ana Carolina Mazarin ^a   Lima, Bruna Araujo ^a   de Faria, Andreia Fonseca ^a   Brocchi, Marcelo ^a   Alves, Oswaldo Luiz ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antibacterial agent; Escherichia coli; Graphene oxide; Graphene oxide silver nanocomposite; MRSA; Silver nanoparticles

Indexed keywords

BIOCIDE; CITRATE SODIUM; GRAPHENE OXIDE; NANOSHEET; OXACILLIN; SILVER; SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; GRAPHITE; METAL NANOPARTICLE; WATER;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL VIABILITY; CONTROLLED STUDY; DISPERSION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; REDUCTION; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG EFFECTS;

ANTI-BACTERIAL AGENTS; GRAPHITE; METAL NANOPARTICLES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SILVER; WATER;

EID: 84946593803     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S90660     Document Type: Article

References (65)

1. Maple PAC, Hamilton-Miller JM, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet. 1989; 1:537-540.
2. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001; 9:486-493.
3. Bereket W, Hemalatha K, Getenet B, et al. Update on bacterial nosocomial infections. Eur Rev Med Pharmacol Sci. 2012;16:1039-1044.
4. Ayliffe GAJ. Recommendations for the Control of Methicillin-Resistant Staphylococcus aureus (MRSA). Geneva, Switzerland: World Health Organization. 2012. Available from: http://apps.who.int/medicinedocs/documents/s16211e/s16211e.pdf. Accessed February 2, 2015.
5. Emerging Infections Program Network. Active Bacterial Core Surveillance Report. Methicillin-resistant Staphylococcus aureus. Atlandta, GA: Centers for Disease Control and Prevention; 2012. Available from: http://www.cdc.gov/abcs/reports-findings/survreports/mrsa12.pdf. Accessed February 2, 2015.
6. Alvarez C, Labarca J, Salles M. Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Braz J Infect Dis. 2010;14:S107-S118.
7. Michel M, Gutmann L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet. 1997;349:1901-1906.
8. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century - a clinical super-challenge. N Engl J Med. 2009;360:439-443.
9. Taylor E, Webster TJ. Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine. 2011;6:1463-1473.
10. Huh AJ, Kwon YJ. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156:128-145.
11. Dreyer DR, Todd AD, Bielawski CW. Harnessing the chemistry of graphene oxide. Chem Soc Rev. 2014;43:5288-5301.
12. Kanakia S, Toussaint JD, Chowdhury SM, et al. Physicochemical characterization of a novel graphene-based magnetic resonance imaging contrast agent. Int J Nanomedicine. 2013;8:2821-2833.
13. Lalwani G, Henslee AM, Farshid B, et al. Two-dimensional nanostructure-reinforced biodegradable polymeric nanocomposites for bone tissue engineering. Biomacromolecules. 2013;14:900-909.
14. Liu JQ, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013;9:9243-9257.
15. Durán N, Martinez DS, Silveira CP, et al. Graphene oxide: a carrier for pharmaceuticals and a scaffold for cell interactions. Curr Top Med Chem. 2015;15:309-327.
16. Talukdar Y, Rashkow JT, Lalwani G, Kanakia S, Sitharaman B. The effects of graphene nanostructures on mesenchymal stem cells. Biomaterials. 2014;35:4863-4877.
17. Mullikc Chowdhury S, Lalwani G, Zhang K, Yang JY, Neville K, Sitharaman B. Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials. 2013;34:283-293.
18. de Faria AF, Perreault F, Shaulsky E, Arias Chavez LH, Elimelech M. Antimicrobial electrospun biopolymer nanofiber mats functionalized with graphene oxide-silver nanocomposites. ACS Appl Mater Interfaces. 2015;7:12751-12759.
19. de Faria AF, Martinez DST, Meira SM, et al. Anti-adhesion and antibacterial activity of silver nanoparticles supported on graphene oxide sheets. Colloids Surf B Biointerfaces. 2014;113:115-124.
20. Das MR, Sarma RK, Saikia R, Kale VS, Shelke MV, Sengupta P. Synthesis of silver nanoparticles in an aqueous suspension of graphene oxide sheets and its antimicrobial activity. Colloids Surf B Biointerfaces. 2011;83:16-22.
21. Ma JZ, Zhang JT, Xiong ZG, Yong Y, Zhao XS. Preparation, characterization and antibacterial properties of silver-modified graphene oxide. J Mater Chem. 2011;21:3350-3352.
22. Zhou Y, Yang J, He T, Shi H, Cheng X, Lu Y. Highly stable and dispersive silver nanoparticle-graphene composites by a simple and low-energy-consuming approach and their antimicrobial activity. Small. 2013;9:3445-3454.
23. Xu WP, Zhang LC, Li JP, et al. Facile synthesis of silver-graphene oxide nanocomposites and their enhanced antibacterial properties. J Mater Chem. 2011;21:4593-4597.
24. Shen JF, Shi M, Li N, et al. Facile synthesis and application of Ag-chemically converted graphene nanocomposite. Nano Res. 2010;3:339-349.
25. Tang J, Chen Q, Xu LG, et al. Graphene oxide-silver nanocomposite as a highly effective antibacterial agent with species-specific mechanisms. ACS Appl Mater Interfaces. 2013;5:3867-3874.
26. Marambio-Jones C, Hoek EM. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res. 2010;12:1531-1551.
27. Lok CN, Ho CM, Chen R, et al. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem. 2007;12:527-534.
28. Tung VC, Allen MJ, Yang Y, Kaner RB. High-throughput solution processing of large-scale graphene. Nat Nanotechnol. 2009;4:25-29.
29. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc. 1951;11:55-75.
30. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Vol 35. 8th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
31. Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 2001;357:1225-1240.
32. Wan WB, Zhao Z, Hu H, Gogotsi Y, Qiu J. Highly controllable and green reduction of graphene oxide to flexible graphene film with high strength. Mater Res Bull. 2013;48:4797-4803.
33. de Faria AF, de Moraes ACM, Marcato PD, et al. Eco-friendly decoration of graphene oxide with biogenic silver nanoparticles: antibacterial and antibiofilm activity. J Nanopart Res. 2014;16:1-16.
34. Li J, Liu CY. Ag/graphene heterostructures: synthesis, characterization and optical properties. Eur J Inorg Chem. 2010;8:1244-1248.
35. Faria AF, Martinez DST, Moraes AC, et al. Unveiling the role of oxidation debris on the surface chemistry of graphene through the anchoring of Ag nanoparticles. Chem Mater. 2012;24:4080-4087.
36. Zhang Z, Chen H, Xing C, et al. Sodium citrate: A universal reducing agent for reduction/decoration of graphene oxide with au nanoparticles. Nano Res. 2011;4:599-611.
37. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002;99:7687-7692.
38. Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine. 2012;7:2767-2781.
39. Seo Y, Hwang J, Kim J, Jeong Y, Hwang MP, Choi J. Antibacterial activity and cytotoxicity of multi-walled carbon nanotubes decorated with silver nanoparticles. Int J Nanomedicine. 2014;9:4621-4629.
40. Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4:5731-5736.
41. Hu WB, Peng C, Luo WJ, et al. Graphene-based antibacterial paper. ACS Nano. 2010;4:4317-4323.
42. Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine. 2012;8:37-45.
43. Martinez-Gutierrez F, Olive PL, Banuelos A, et al. Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine. 2010;6:681-688.
44. Ayala-Núñez NV, Villegas HHL, Turrent LDCI, Padilla CR. Silver nanoparticles toxicity and bactericidal effect against methicillin-resistant Staphylococcus aureus: nanoscale does matter. Nanobiotechnology. 2009;5:2-9.
45. Liu L, Liu JC, Wang Y, Yan X, Sun DD. Facile synthesis of monodispersed silver nanoparticles on graphene oxide sheets with enhanced antibacterial activity. New J Chem. 2011;35:1418-1423.
46. Durante-Mangoni E, Utili R, Zarrilli R. Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date. Future Microbiol. 2014;9:773-789.
47. Werner G, Coque TM, Franz CM, et al. Antibiotic resistant enterococci - tales of a drug resistance gene trafficker. Int J Med Microbiol. 2013;303:360-379.
48. Amany A, El-Rab SFG. Effect of reducing and protecting agents on size of silver nanoparticles and their anti-bacterial activity. Der Pharma Chemica. 2012;4:53-65.
49. Borah D, Deka P, Bhattacharjee P, Changmai A, Yadav RNS. Ocimum sanctum mediated silver nano particles showed better antimicrobial activities compared to citrate stabilized silver nano particles against multidrug resistant bacteria. J Pharm Res. 2013;7:478-482.
50. Taner M, Sayar N, Yulug IG, Suzer S. Synthesis, characterization and antibacterial investigation of silver-copper nanoalloys. J Mater Chem. 2011;21:13150-13154.
51. Barua S, Thakur S, Aidew L, Buragohain AK, Chattopadhyay P, Karak N. One step preparation of a biocompatible, antimicrobial reduced graphene oxide-silver nanohybrid as a topical antimicrobial agent. RSC Adv. 2014;4:9777-9783.
52. Han YJ, Luo ZM, Yuwen L, Tian J, Zhu X, Wang L. Synthesis of silver nanoparticles on reduced graphene oxide under microwave irradiation with starch as an ideal reductant and stabilizer. Appl Surf Sci. 2013;266:188-193.
53. Tian TF, Shi XZ, Cheng L, et al. Graphene-based nanocomposite as an effective, multifunctional, and recyclable antibacterial agent. ACS Appl Mater Inter. 2014;6:8542-8548.
54. Liu SB, Zeng TH, Hofmann M, et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano. 2011;5:6971-6980.
55. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine. 2012; 7:5901-5914.
56. Sanchez VC, Jachak A, Hurt RH, Kane AB. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol. 2012;25:15-34.
57. Ruiz ON, Fernando KA, Wang B, et al. Graphene oxide: a nonspecific enhancer of cellular growth. ACS Nano. 2011;5:8100-8107.
58. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27:76-83.
59. Morones JR, Elechiguerra JL, Camacho A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346-2353.
60. Tu YS, Lv M, Xiu P, et al. Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets. Nat Nanotechnol. 2013;8:594-601.
61. Durán N, Marcato PD, Conti RD, Alves OL, Costa F, Brocchi M. Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc. 2010;21:949-959.
62. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73:1712-1720.
63. Holtz RD, Lima BA, Souza AG, Brocchi M, Alves OL. Nanostructured silver vanadate as a promising antibacterial additive to water-based paints. Nanomedicine. 2012;8:935-940.
64. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275:177-182.
65. Raffi M, Hussain F, Bhatti TM, Akhter JI, Hameed A, Hasan MM. Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224. J Mater Sci Technol. 2008;24:192-196.